Literature DB >> 17726734

Dosing effects of an antiosteoporosis herbal formula--a preclinical investigation using a rat model.

Ye Sun1, Simon Ming Yuen Lee, Yin Mei Wong, Ching Po Lau, Pang Chui Shaw, Ling Qin, Ping Chung Leung, Kwok Pui Fung.   

Abstract

Herba Epimedii, Fructus Ligustri Lucidi and Fructus Psoraleae are three frequently used Chinese herbs traditionally used for tonifying the 'kidney system'. They were selected for the present study to formulate an herbal preparation with a weight ratio of 5:4:1 based on their phytochemical, nature, documented treatment efficacy and toxicity. The dosing effects (1 g/day, 0.5 g/day and 0.175 g/day) of the antiosteoporosis function of the water extract of this formula were tested in ovariectomy- and calcium deficiency-induced osteoporotic rats. Eleven weeks of herbal treatment demonstrated a beneficial effect on the preservation of bone mineral density (BMD) at the femur neck in a dose-dependent manner with the preference for higher dosage. No significant increase in uterus weight was observed in the herbal formula treated rats. In addition, microarray data of kidney tissue revealed that this herbal formula was able to down-regulate the expression of phase II drug metabolizing enzymes, similar to the effects of estrogens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17726734     DOI: 10.1002/ptr.2291

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  9 in total

1.  Application of Chinese herbal medicines to revitalize adult stem cells for tissue regeneration.

Authors:  Hing-Lok Wong; Wing-sum Siu; Wai-ting Shum; Si Gao; Ping-Chung Leung; Chun-Hay Ko
Journal:  Chin J Integr Med       Date:  2012-12-13       Impact factor: 1.978

Review 2.  Molecular genetic studies of gene identification for osteoporosis: the 2009 update.

Authors:  Xiang-Hong Xu; Shan-Shan Dong; Yan Guo; Tie-Lin Yang; Shu-Feng Lei; Christopher J Papasian; Ming Zhao; Hong-Wen Deng
Journal:  Endocr Rev       Date:  2010-03-31       Impact factor: 19.871

3.  An innovative herbal product for the prevention of osteoporosis.

Authors:  Ping-chung Leung; King-fai Cheng; Yat-heung Chan
Journal:  Chin J Integr Med       Date:  2011-11-19       Impact factor: 1.978

4.  Seropharmacological study on osteogenic effects of post-absorption ingredients of an osteoprotective herbal formula.

Authors:  Wing-Sum Siu; Chun-Hay Ko; Hing-Lok Wong; Si Gao; Wai-Ting Shum; Clara Bik-San Lau; Lung-Kim Hung; Ping-Chung Leung
Journal:  Chin J Integr Med       Date:  2016-06-14       Impact factor: 1.978

5.  Bone protection effects of a novel Chinese herbal formula, taikong yangxin prescription, in hindlimb unloaded rats against bone deterioration.

Authors:  Chun-hay Ko; Wing-sum Siu; Chung-lap Chan; Chi-man Koon; Kwok-pui Fung; Yong-zhi Li; Ying-hui Li; Ping-chung Leung
Journal:  Chin J Integr Med       Date:  2015-11-03       Impact factor: 1.978

6.  Osteoprotective effects of Fructus Ligustri Lucidi aqueous extract in aged ovariectomized rats.

Authors:  Chun Hay Ko; Wing Sum Siu; Ching Po Lau; Clara Bik San Lau; Kwok Pui Fung; Ping Chung Leung
Journal:  Chin Med       Date:  2010-11-29       Impact factor: 5.455

Review 7.  DNA Microarray-Based Screening and  Characterization of Traditional Chinese Medicine.

Authors:  Ryoiti Kiyama
Journal:  Microarrays (Basel)       Date:  2017-01-30

8.  Systems biology of meridians, acupoints, and chinese herbs in disease.

Authors:  Li-Ling Lin; Ya-Hui Wang; Chi-Yu Lai; Chan-Lao Chau; Guan-Chin Su; Chun-Yi Yang; Shu-Ying Lou; Szu-Kai Chen; Kuan-Hao Hsu; Yen-Ling Lai; Wei-Ming Wu; Jian-Long Huang; Chih-Hsin Liao; Hsueh-Fen Juan
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-18       Impact factor: 2.629

9.  In Vivo Study on the Pharmacological Interactions between a Chinese Herbal Formula ELP and Antiresorptive Drugs to Counteract Osteoporosis.

Authors:  Chun-Hay Ko; Wing-Sum Siu; Hing-Lok Wong; Si Gao; Wai-Ting Shum; Ching-Po Lau; Sau-Wan Cheng; Jacqueline Chor-Wing Tam; Leung-Kim Hung; Kwok-Pui Fung; Clara Bik-San Lau; Quan-Bin Han; Ping-Chung Leung
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-24       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.